You are here: Home » News-ANI » National
Business Standard

'No shortage of medicines to combat COVID-19'

Health Medical Pharma

ANI  |  General News 

The Department of Pharmaceuticals, under Ministry of Chemicals and Fertilisers, is continuously monitoring the distribution and addressing issues of availability, supply and local related issues of medicines with the help of other departments, states and Union Territories (UTs).

A central control room (011-23389840) has been set up in the Department of Pharmaceuticals, which is working from 8 am to 6 pm, read a statement.

The Pharmaceutical Pricing Authority (NPPA) has set up another control room - helpline number 1800111255 - which functions round the clock. The control rooms deal with issues related to queries and complaints and messages dealing with COVID-19 as well as coordination of transport and other logistic services related to drugs and medical devices.

The Department of Pharmaceuticals is working in close coordination with line departments like Ministry of Health and Family Welfare, Ministry of Commerce and Industry, customs authorities, Central and State Drug Controllers, state governments, UTs, and various drugs and medical device associations, the statement added.

Also, it is continuously monitoring the production of medicines since the outbreak of coronavirus in China. After the lockdown, the department is facilitating the industry by addressing various issues arising from time to time as quickly as possible on top priority in consultation with various authorities including state and Union Territory governments.

"In case any issue pertaining to other Ministries/Departments comes or are brought to DoPs attention, the same is being flagged to the authorities concerned as a part of inter-departmental coordination and through empowered groups," it said.

The NPPA has directed manufacturers to produce and maintain sufficient stocks of essential drugs at any point of time. All efforts are made to ensure the production of drugs and medical devices during the period of lockdown, the statement added.

The Department of Pharmaceuticals is using digital platforms forming WhatsApp groups/email systems and using video conferencing facilities to ensure prompt action at various levels.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, March 31 2020. 20:01 IST